Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.

Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.

Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.

Abstract: Compounds for treating neurodegenerative disorders The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.

Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.

Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.

Abstract: The invention relates to a composition containing a Withania somnifera extract, obtained by fermentation by incubating the Withania somnifera extract with a filamentous fungus of the Beauveria genus. The composition can be used to treat or prevent ?-synucleinopathies in a subject.

Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.

Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.

Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to prevent, treat of delay the progression of ?-synuclemopathies, including Parkinson disease.

Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.

Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.

Abstract: The present invention relates to the use of one or more shogaol(s) as aphrodisiacs. Advantageously, the shogaol(s) correspond(s) to the general formula I: in which n is equal to 1, 2, 4, 6 or 8 and advantageously 1. The present invention also relates to a process for stimulating or arousing the libido in human beings, comprising the administration to a human being of an effective amount of one or more shogaol(s).

Abstract: A composition comprising at least one absorbent and at least one non-metabolizable sugar, and a method for using the composition, for promoting cell regeneration and/or cell differentiation.

Abstract: The invention relates to the use of a vallinoid to diminish, suppress or prevent snoring and in the production of a medicament for the treatment of sleep apnoea. Preferably, the vallinoid is selected from the group comprising capsaicin, piperine, gingerols and shogaols.

Abstract: The present invention provides an oral composition comprising an effective quantity of an Albizzia myriophylla bark extract to suppress or reduce the gustatory function, in particular as regards a bitter and/or sweet and/or acid taste, advantageously a bitter and/or sweet taste, and a suitable excipient. It also provides the use of an Albizzia myriophylla bark extract or of an oral composition in accordance with the invention, to suppress or reduce the gustatory function. Finally, it provides an Albizzia myriophylla bark extract or a composition in accordance with the invention as a drug, in particular intended for the treatment of bulimia, a compulsive eating disorder, alcohol and/or nicotine dependence obesity and for the prevention of obesity.

Abstract: A method is provided for suppressing body odors in a human by administering orally to the human or applying to the skin of the human, at least one compound chosen from the group consisting of shogaols and gingerols. The compound corresponds to the general formula: in which X represents: either —CH═CH—, in which case n is equal to 1, 2, 4, 6, or 8; —CH2—CH(OH)—, in which case n is equal to 2, 4, 6 or 8.

Abstract: A pharmaceutical composition for topical application to and treatment of lesion of connective tissue by acting on fibrillar and microfibrillar structures, proelastin, and/or on the fundamental substance and its collagen, the essential active constituent being an Alchemilla extract.

Abstract: The present invention describes a method and apparatus for selectively transmitting information by radio, without causing congestion of transmission frequency bands, even if the number of users who may be called is relatively great. This object is achieved by ensuring the identification of the users by a decoding matrix provided in each of the receiver devices assigned to each of the users; the pulses characterising a call code are introduced into a shift register and compared with the decoding matrix; when the corresponding binary words are identical, the call signal of the receiver is sent whether it is a sound and/or like call, also the shift register is used to record the details corresponding to the information to be transmitted and then to present said information in alphanumerical form.